1-3 of 3
Talha Munir
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN Study

Open Access
Clinical Trials & Observations
Nirav N Shah, Pier Luigi Zinzani, Michael L Wang, Sunita D. Nasta, Ewa Lech-Maranda, Yoshiaki Ogawa, Bita Fakhri, Bryone Jean Kuss, Kaname Miyashita, Krish Patel, Catherine C. Coombs, Shuo Ma, Manish R. Patel, Minal Barve, Benoit Tessoulin, Anastasios Stathis, Daisuke Ennishi, Daigo Hashimoto, Kensuke Kojima, Andrew D. Zelenetz, Jonathon B Cohen, Julie M Vose, Kami J Maddocks, Talha Munir, Fangfang Sun, Yuanyuan Bian, Minna Balbas, Donald E Tsai, Paolo B. Abada, Chan Y Cheah
Journal: Blood Advances
Blood Adv bloodadvances.2024014975.
https://doi.org/10.1182/bloodadvances.2024014975
Published: 2025
Includes: Supplemental data
Journal Articles

Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

Open Access
Clinical Trials & Observations
Constantine S Tam, Mary Ann Anderson, Martin Simkovic, Paolo Ghia, Ian W. Flinn, Kamel Laribi, Stephen S. Opat, Gavin Cull, Talha Munir, Anders Österborg, Alessandra Tedeschi, Megan (Der Yu) Wang, Andy H. Szeto, Heather Allewelt, Tommi Salmi, Jessica Li, Linlin Xu, Kenneth Wu, Remus Vezan, Mazyar Shadman, Jennifer R. Brown
Journal: Blood Advances
Blood Adv bloodadvances.2025015986.
https://doi.org/10.1182/bloodadvances.2025015986
Published: 2025
Includes: Supplemental data
Journal Articles

Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates

Open Access
Clinical Trials & Observations
Ana Rita da Fonseca, Caio Cesar Justino, Vinicius Campos de Molla, Patricia Eiko Yamakawa, Iara Baldim Rabelo, Louise Arnold, Richard Kelly, Morag Griffin, Talha Munir, Anita Hill, Elvira Velloso, Thales Dalessandro, Antonio M. Risitano, Phillip Scheinberg, Austin Kulasekararaj, Celso Arrais-Rodrigues
Journal: Blood Advances
Blood Adv (2025) 9 (4): 906–912.
https://doi.org/10.1182/bloodadvances.2024014159
Published: 2025